DefenceOne outlet
First reported / 20 Nov 08:51:38 UTC by The Express Tribune.
Artificial intelligence has sped up early-stage drug development work at some of the world's largest pharmaceutical companies this year, cutting by as much as half the time it takes to produce new molecules and move them into the clinic, according to their top scientists. GSK, Bristol Myers Squibb, Novartis, Eli...